Sonnet BioTherapeutics, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • Overview
    • Platform
    • Strategy
    • Progress
    • Publications
  • Pipeline
    • Overview
    • Clinical Trials
  • Partnering
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact

Press Releases

News & Media

News & Media

  • Press Releases
  • Presentations
  • Events
Jul 22, 2022 7:00am EDT

Sonnet BioTherapeutics Announces Clinical Trial of SON-080 in Patients with Persistent Chemotherapy-Induced Peripheral Neuropathy

Jul 21, 2022 7:30am EDT

Sonnet BioTherapeutics Announces Clinical Trial of SON-1010 in Healthy Volunteers

Jun 09, 2022 7:00am EDT

Sonnet BioTherapeutics Announces Positive Results from a Preclinical Combination Study of SON-1010 with anti-PD1 Checkpoint Inhibition

Jun 02, 2022 9:25am EDT

Sonnet BioTherapeutics Announces Adjournment of Annual Meeting Due to Lack of Quorum

May 10, 2022 8:15am EDT

Sonnet BioTherapeutics Provides Fiscal Year 2022 Second Quarter Business and Earnings Update

Apr 13, 2022 7:00am EDT

Sonnet BioTherapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of SON-1010 for Advanced Solid Tumors

Apr 08, 2022 1:05pm EDT

Sonnet BioTherapeutics Announces Preclinical Data Supporting Its Bispecific Interleukin Candidates at the American Association for Cancer Research (AACR) 2022 Annual Meeting

Mar 16, 2022 7:00am EDT

Sonnet BioTherapeutics Announces FDA Clearance of Its IND for SON-1010 for the Treatment of Advanced Solid Tumors

Feb 09, 2022 6:30am EST

Sonnet BioTherapeutics Announces Abstract Accepted for Presentation in a Poster Session at the AACR 2022 Annual Meeting

Feb 08, 2022 7:00am EST

Sonnet BioTherapeutics Provides Fiscal Year 2022 First Quarter Business and Earnings Update

RSS
  • Prev
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    Next
    © 2023 Sonnet BioTherapeutics, Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap